Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS

Abstract INTRODUCTION: Despite expanding use of plasma biomarkers for Alzheimer's disease (AD), minimal examination has been undertaken in early‐onset AD (EOAD). Prior analyses assessed criterion and convergent validity of common plasma biomarkers in a well‐characterized sample with sporadic EOAD. M...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dustin B. Hammers, Angelina Polsinelli, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Tatiana Foroud, Sujuan Gao, Laurel Beckett, Renaud La Joie, Alexandra Touroutoglou, Prashanthi Vemuri, Henrik Zetterberg, Kaj Blennow, Sára Nemes, Ralitsa Kostadinova, Paul Aisen, Kelly N. Nudelman, Kala Kirby, Alireza Atri, David Clark, Gregory S. Day, Ranjan Duara, Neill R. Graff‐Radford, Ian Grant, Lawrence S. Honig, Erik C. B. Johnson, David T. Jones, Joseph C. Masdeu, Mario F. Mendez, Leila Parand, Kyle Womack, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, Raymond Scott Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Gil D. Rabinovici, Bradford C. Dickerson, Jeffrey L. Dage, Liana G. Apostolova, the LEADS Consortium
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
coleção:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Assuntos:	cognition early‐onset Alzheimer's disease magnetic resonance imaging MRI positron emission tomography PET
Acesso em linha:	https://doi.org/10.1002/dad2.70342
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!